Blood test using AI and nanotechnology sorted Parkinson's stages, a study found
Researchers developed PANDA, a plasmonic nanotechnology system that measures the size distribution of alpha-synuclein aggregates in human serum through immunogold clustering scattering signatures, and combined it with a deep neural network to classify Parkinson's disease stages.
Advanced Materials
ace